Acadia Pharmaceuticals
Colin O'Carroll is a seasoned professional in the biotechnology and pharmaceutical sectors with significant experience in translational medicine, research, and program management. Currently serving as Senior Director of Translational Medicine at ACADIA Pharmaceuticals Inc. since December 2019, Colin leads efforts to support drug development, notably the successful NDA submission for Trofinetide. Prior roles include Director of Research & Program Management at Reneo Pharmaceuticals, where Colin managed IND enabling processes, and Consultant at Ardmore Biotech Consulting, providing strategic advice to biotech firms. Previous positions also include Senior Manager of Corporate Development at Synthorx Inc., where Colin contributed to a successful IPO, and Senior Scientist at Dart NeuroScience, focusing on CNS drug targets. Colin is pursuing a Master of Science in Pharmacometrics at the University of Maryland, Baltimore, following an MBA in Finance, Investment & Entrepreneurship from the University of California, San Diego.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.